Cargando…
The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials
BACKGROUND: HIV-associated lipodystrophy syndrome (HALS) is characterized by insulin resistance, abnormal lipid metabolism and redistribution of body fat. To date, there has been no quantitative summary of the effects of insulin sensitizing-agents for the treatment of this challenging problem. METHO...
Autores principales: | Sheth, Siddharth H, Larson, Robin J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906460/ https://www.ncbi.nlm.nih.gov/pubmed/20573187 http://dx.doi.org/10.1186/1471-2334-10-183 |
Ejemplares similares
-
Insulin lipodystrophy and lipohypertrophy
por: Mokta, Jatinder K., et al.
Publicado: (2013) -
Biochemical Manifestation of HIV Lipodystrophy Syndrome
por: Ihenetu, Kenneth, et al.
Publicado: (2012) -
Local Lipodystrophy Following Insulin Injections
Publicado: (1930) -
Lipodystrophy and metabolic syndrome in Romanian HIV-infected adults
por: Arbune, M
Publicado: (2010) -
Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome
por: Donadille, Bruno, et al.
Publicado: (2013)